Ibuprofen (MOMENT ACT ANALGESIC Granules) Pharmacokinetic Study

Phase 1 Completed 24 enrolled Angelini Pharma Cross Research S.A. · collab

NaSingle-groupOpen-label

Summary

The main purpose of this study was to evaluate the pharmacokinetic (PK) profile of ibuprofen after oral administration of a single dose of MOMENT ACT ANALGESIC granules to healthy male and female subjects, under fasting conditions.

Timeline

Start: 2015-02
Primary completion: 2015-03
Completion: 2015-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ibuprofen	Small molecule	400 mg	Oral

Indications

No indication recorded.